Using smartwatches to monitor heart and exercise health
Wearable Assessment of Thoracic, Cardiac Health and Exercise Performance Trial
The University of Hong Kong · NCT06671171
This study is testing if the Apple Watch Series 9 can accurately track heart and exercise health in people aged 20 to 70 who have certain heart conditions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 20 Years to 70 Years |
| Sex | All |
| Sponsor | The University of Hong Kong (other) |
| Drugs / interventions | cart |
| Locations | 1 site (Hong Kong) |
| Trial ID | NCT06671171 on ClinicalTrials.gov |
What this trial studies
This observational trial aims to validate the accuracy of wearable health technology, specifically the Apple Watch Series 9, in monitoring various physiological parameters relevant to cardiovascular health. Participants aged 20 to 70 with a history of congenital heart disease, pulmonary hypertension, heart failure, or coronary artery disease will be recruited from Queen Mary Hospital and the University of Hong Kong. The study will involve collecting comprehensive demographic and clinical data, conducting a baseline clinical examination, and performing a cardiopulmonary exercise test to assess participants' maximal oxygen uptake. The goal is to explore the potential of smartwatches in aiding disease progression monitoring and predicting adverse events in cardiovascular patients.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 20 to 70 with a history of specific cardiovascular conditions or athletes undergoing cardiovascular assessment.
Not a fit: Patients who are pregnant, have contraindications for physical exertion, or have known allergies to smartwatch components may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the ability to monitor cardiovascular health and improve patient outcomes through continuous, non-invasive tracking.
How similar studies have performed: While the use of wearable technology in health monitoring is gaining traction, this specific validation against medical-grade devices is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 20 to 70 years old * Ability to provide informed consent * History of the following cardiovascular conditions * Adult congenital heart disease * Pulmonary hypertension * Heart failure * Coronary artery disease * Athletes undergoing cardiovascular assessment Exclusion Criteria: * Contraindication for undergoing physical exertion including cardio-pulmonary exercise testing (CPX) and 6-minute walk test (6MWT) * Pregnancy * Known allergy to components of the investigational product
Where this trial is running
Hong Kong
- Department of Medicine Queen Marry Hospital — Hong Kong, Hong Kong (RECRUITING)
Study contacts
- Study coordinator: Chun Ka Dr Wong, Clinical Assistant Professor
- Email: wongeck@hku.hk
- Phone: +852-22553111
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Congenital Heart Disease, Pulmonary Hypertension, Heart Failure, Coronary Artery Disease, congenital heart disease, pulmonary hypertension, heart failure, coronary artery disease